Eden Research (LON:EDEN) Shares Down 3.3% – Time to Sell?

Eden Research plc (LON:EDEN)’s stock price dropped 3.3% during trading on Saturday . The company traded as low as GBX 3.30 ($0.04) and last traded at GBX 3.48 ($0.04). Approximately 450,985 shares changed hands during mid-day trading, a decline of 52% from the average daily volume of 933,021 shares. The stock had previously closed at GBX 3.60 ($0.05).

Eden Research Stock Performance

The company’s 50-day moving average price is GBX 3.88 and its two-hundred day moving average price is GBX 3.95. The company has a market capitalization of £18.56 million, a price-to-earnings ratio of -12.19 and a beta of 0.92. The company has a debt-to-equity ratio of 1.26, a current ratio of 3.80 and a quick ratio of 2.42.

Insider Buying and Selling at Eden Research

In related news, insider Lykele van der Broek acquired 256,000 shares of the stock in a transaction dated Thursday, February 6th. The stock was bought at an average price of GBX 4 ($0.05) per share, for a total transaction of £10,240 ($12,937.46). Also, insider Alexander John Abrey bought 540,540 shares of the business’s stock in a transaction that occurred on Tuesday, January 28th. The shares were bought at an average cost of GBX 4 ($0.05) per share, for a total transaction of £21,621.60 ($27,317.25). Insiders own 14.02% of the company’s stock.

About Eden Research

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.